He has experience as a consultant at Bain and has worked in senior roles at Wyeth/ Pfizer in commercial and R&D. He is a UK GMC registered physician, has an MA from Trinity College, Cambridge and is a graduate of the Sloan Masters management program at London Business School. Areas of focus include new market entry and scenario planning, medical regulatory global optimisation, next generation market access challenges and process redesign. Richard pioneered on biosimilars strategy from 2007 and has extensive experience in many emerging markets. He is an advisor to private equity and investment firms on healthcare and life sciences.